Falch Camilla Maria, Sundaram Arvind Y M, Øystese Kristin Astrid, Normann Kjersti Ringvoll, Lekva Tove, Silamikelis Ivars, Eieland Alexander Kirkeby, Andersen Marianne, Bollerslev Jens, Olarescu Nicoleta Cristina
Section of Specialized EndocrinologyDepartment of Endocrinology
Research Institute for Internal MedicineOslo University Hospital, Oslo, Norway.
Eur J Endocrinol. 2018 Mar;178(3):295-307. doi: 10.1530/EJE-17-0702. Epub 2017 Dec 19.
Reliable biomarkers associated with aggressiveness of non-functioning gonadotroph adenomas (GAs) are lacking. As the growth of tumor remnants is highly variable, molecular markers for growth potential prediction are necessary. We hypothesized that fast- and slow-growing GAs present different gene expression profiles and reliable biomarkers for tumor growth potential could be identified, focusing on the specific role of epithelial-mesenchymal transition (EMT).
Eight GAs selected for RNA sequencing were equally divided into fast- and slow-growing group by the tumor volume doubling time (TVDT) median (27.75 months). Data were analyzed by tophat2, cufflinks and cummeRbund pipeline. 40 genes were selected for RT-qPCR validation in 20 GAs based on significance, fold-change and pathway analyses. The effect of silencing (metadherin) and (endomucin) on migration of human adenoma cells was evaluated.
350 genes were significantly differentially expressed (282 genes upregulated and 68 downregulated in the fast group, -adjusted <0.05). Among 40 selected genes, 11 showed associations with TVDT (-0.669<<-0.46, < 0.05). These were and six EMT-related genes ( and ). , but not , demonstrated involvement in cell migration and association with EMT markers.
Fast- and slow-growing GAs present different gene expression profiles, and genes related to EMT have higher expression in fast-growing tumors. In addition to , identified as an important contributor to aggressiveness, the other genes might represent markers for tumor growth potential and possible targets for drug therapy.
目前缺乏与无功能促性腺激素腺瘤(GA)侵袭性相关的可靠生物标志物。由于肿瘤残余物的生长具有高度变异性,因此需要用于预测生长潜力的分子标志物。我们假设快速生长和缓慢生长的GA呈现不同的基因表达谱,并且可以识别出用于肿瘤生长潜力的可靠生物标志物,重点关注上皮-间质转化(EMT)的特定作用。
根据肿瘤体积倍增时间(TVDT)中位数(27.75个月),将选择用于RNA测序的8个GA平均分为快速生长组和缓慢生长组。数据通过tophat2、cufflinks和cummeRbund管道进行分析。基于显著性、倍数变化和通路分析,在20个GA中选择40个基因进行RT-qPCR验证。评估沉默(黏附素)和(内黏蛋白)对人腺瘤细胞迁移的影响。
350个基因有显著差异表达(快速生长组中282个基因上调,68个基因下调,校正后<0.05)。在40个选定的基因中,11个与TVDT相关(-0.669<<-0.46,<0.05)。这些基因是和6个与EMT相关的基因(和)。,而非,显示参与细胞迁移并与EMT标志物相关。
快速生长和缓慢生长的GA呈现不同的基因表达谱,与EMT相关的基因在快速生长的肿瘤中表达更高。除了被确定为侵袭性的重要促成因素外,其他基因可能代表肿瘤生长潜力的标志物和药物治疗的可能靶点。